特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
957665

がん遺伝子治療の世界市場

Cancer Gene Therapy

出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 129 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.70円

ご注意:Single user licenseはDRM(デジタル著作権管理システム)付PDFとなります。
PDFの閲覧には Adobe Digital Editions (無償)のインストールが必要となります。
認証されたPC上のみでの閲覧と、1回のプリントアウトが可能となっております。

がん遺伝子治療の世界市場
出版日: 2020年09月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 129 Pages
納期: 即日から翌営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

世界のがん遺伝子治療の市場規模は、分析期間(2020年~2027年)に29.6%のCAGRで成長する見通しで、2020年の6億1,190万米ドルから2027年には38億米ドルに達すると予測されています。当レポートで分析されているセグメントの1つである腫瘍溶解性ウイルス療法は、分析期間中に30.3%の年率で成長し、18億米ドルに達すると予測されています。

当レポートは、世界のがん遺伝子治療市場について調査しており、市場シェア、動向や見通し、成長要因、地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

調査対象企業の例

  • Adaptimmune Therapeutics plc
  • Advantagene, Inc.
  • Altor Bioscience (a NANT Company)
  • Anchiano Therapeutics, Inc.
  • bluebird bio, Inc.
  • Genelux Corporation
  • GlaxoSmithKline PLC
  • Merck & Co., Inc.
  • OncoGenex Pharmaceuticals, Inc.
  • Shanghai Sunway Biotech Co., Ltd.
  • Shenzhen SiBiono GeneTech Co., Ltd.
  • ZIOPHARM Oncology, Inc.

目次

I. イントロダクション、調査手法、調査範囲

II. エグゼクティブサマリー

  • 市場概要
    • 競合の市場シェア
    • 競合の市場シェアシナリオ
    • Covid-19の影響と迫り来る世界の景気後退
  • 主要企業
  • 動向と成長要因
  • 世界市場の見通し

III. 市場分析

  • 地域別市場分析
  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

IV. 競合

  • 企業プロファイル:42社
目次
Product Code: MCP10864

Global Cancer Gene Therapy Market to Reach $3.8 Billion by 2027

Amid the COVID-19 crisis, the global market for Cancer Gene Therapy estimated at US$611.9 Million in the year 2020, is projected to reach a revised size of US$3.8 Billion by 2027, growing at a CAGR of 29.6% over the analysis period 2020-2027. Oncolytic Virotherapy, one of the segments analyzed in the report, is projected to record a 30.3% CAGR and reach US$1.8 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Gene Transfer Therapy segment is readjusted to a revised 28.1% CAGR for the next 7-year period.

The U.S. Market is Estimated at $183.8 Million, While China is Forecast to Grow at 28.7% CAGR

The Cancer Gene Therapy market in the U.S. is estimated at US$183.8 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$641.9 Million by the year 2027 trailing a CAGR of 28.7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 26.7% and 25.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 20.7% CAGR.

Gene-Induced Immunotherapy Segment to Record 30.5% CAGR

In the global Gene-Induced Immunotherapy segment, USA, Canada, Japan, China and Europe will drive the 30.5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$89.5 Million in the year 2020 will reach a projected size of US$575.9 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$447 Million by the year 2027.We bring years of research experience to this 5th edition of our report. The 129-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • Adaptimmune Therapeutics plc
  • Advantagene, Inc.
  • Altor Bioscience (a NANT Company)
  • Anchiano Therapeutics, Inc.
  • bluebird bio, Inc.
  • Genelux Corporation
  • GlaxoSmithKline PLC
  • Merck & Co., Inc.
  • OncoGenex Pharmaceuticals, Inc.
  • Shanghai Sunway Biotech Co., Ltd.
  • Shenzhen SiBiono GeneTech Co., Ltd.
  • ZIOPHARM Oncology, Inc.

TABLE OF CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Global Competitor Market Shares
    • Cancer Gene Therapy Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: Cancer Gene Therapy Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2020-2027
    • TABLE 2: Cancer Gene Therapy Global Retrospective Market Scenario in US$ Thousand by Region/Country: 2012-2019
    • TABLE 3: Cancer Gene Therapy Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027
    • TABLE 4: Oncolytic Virotherapy (Segment) World Market by Region/Country in US$ Thousand: 2020 to 2027
    • TABLE 5: Oncolytic Virotherapy (Segment) Historic Market Analysis by Region/Country in US$ Thousand: 2012 to 2019
    • TABLE 6: Oncolytic Virotherapy (Segment) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027
    • TABLE 7: Gene Transfer Therapy (Segment) Potential Growth Markets Worldwide in US$ Thousand: 2020 to 2027
    • TABLE 8: Gene Transfer Therapy (Segment) Historic Market Perspective by Region/Country in US$ Thousand: 2012 to 2019
    • TABLE 9: Gene Transfer Therapy (Segment) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027
    • TABLE 10: Gene-Induced Immunotherapy (Segment) Geographic Market Spread Worldwide in US$ Thousand: 2020 to 2027
    • TABLE 11: Gene-Induced Immunotherapy (Segment) Region Wise Breakdown of Global Historic Demand in US$ Thousand: 2012 to 2019
    • TABLE 12: Gene-Induced Immunotherapy (Segment) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Cancer Gene Therapy Market Share (in %) by Company: 2019 & 2025
    • Market Analytics
    • TABLE 13: United States Cancer Gene Therapy Market Estimates and Projections in US$ Thousand by Segment: 2020 to 2027
    • TABLE 14: Cancer Gene Therapy Market in the United States by Segment: A Historic Review in US$ Thousand for 2012-2019
    • TABLE 15: United States Cancer Gene Therapy Market Share Breakdown by Segment: 2012 VS 2020 VS 2027
  • CANADA
    • TABLE 16: Canadian Cancer Gene Therapy Market Estimates and Forecasts in US$ Thousand by Segment: 2020 to 2027
    • TABLE 17: Canadian Cancer Gene Therapy Historic Market Review by Segment in US$ Thousand: 2012-2019
    • TABLE 18: Cancer Gene Therapy Market in Canada: Percentage Share Breakdown of Sales by Segment for 2012, 2020, and 2027
  • JAPAN
    • TABLE 19: Japanese Market for Cancer Gene Therapy: Annual Sales Estimates and Projections in US$ Thousand by Segment for the Period 2020-2027
    • TABLE 20: Cancer Gene Therapy Market in Japan: Historic Sales Analysis in US$ Thousand by Segment for the Period 2012-2019
    • TABLE 21: Japanese Cancer Gene Therapy Market Share Analysis by Segment: 2012 VS 2020 VS 2027
  • CHINA
    • TABLE 22: Chinese Cancer Gene Therapy Market Growth Prospects in US$ Thousand by Segment for the Period 2020-2027
    • TABLE 23: Cancer Gene Therapy Historic Market Analysis in China in US$ Thousand by Segment: 2012-2019
    • TABLE 24: Chinese Cancer Gene Therapy Market by Segment: Percentage Breakdown of Sales for 2012, 2020, and 2027
  • EUROPE
    • Market Facts & Figures
    • European Cancer Gene Therapy Market: Competitor Market Share Scenario (in %) for 2019 & 2025
    • Market Analytics
    • TABLE 25: European Cancer Gene Therapy Market Demand Scenario in US$ Thousand by Region/Country: 2020-2027
    • TABLE 26: Cancer Gene Therapy Market in Europe: A Historic Market Perspective in US$ Thousand by Region/Country for the Period 2012-2019
    • TABLE 27: European Cancer Gene Therapy Market Share Shift by Region/Country: 2012 VS 2020 VS 2027
    • TABLE 28: European Cancer Gene Therapy Market Estimates and Forecasts in US$ Thousand by Segment: 2020-2027
    • TABLE 29: Cancer Gene Therapy Market in Europe in US$ Thousand by Segment: A Historic Review for the Period 2012-2019
    • TABLE 30: European Cancer Gene Therapy Market Share Breakdown by Segment: 2012 VS 2020 VS 2027
  • FRANCE
    • TABLE 31: Cancer Gene Therapy Market in France by Segment: Estimates and Projections in US$ Thousand for the Period 2020-2027
    • TABLE 32: French Cancer Gene Therapy Historic Market Scenario in US$ Thousand by Segment: 2012-2019
    • TABLE 33: French Cancer Gene Therapy Market Share Analysis by Segment: 2012 VS 2020 VS 2027
  • GERMANY
    • TABLE 34: Cancer Gene Therapy Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Segment for the Period 2020-2027
    • TABLE 35: German Cancer Gene Therapy Historic Market Analysis in US$ Thousand by Segment: 2012-2019
    • TABLE 36: German Cancer Gene Therapy Market Share Breakdown by Segment: 2012 VS 2020 VS 2027
  • ITALY
    • TABLE 37: Italian Cancer Gene Therapy Market Growth Prospects in US$ Thousand by Segment for the Period 2020-2027
    • TABLE 38: Cancer Gene Therapy Historic Market Analysis in Italy in US$ Thousand by Segment: 2012-2019
    • TABLE 39: Italian Cancer Gene Therapy Market by Segment: Percentage Breakdown of Sales for 2012, 2020, and 2027
  • UNITED KINGDOM
    • TABLE 40: United Kingdom Market for Cancer Gene Therapy: Annual Sales Estimates and Projections in US$ Thousand by Segment for the Period 2020-2027
    • TABLE 41: Cancer Gene Therapy Market in the United Kingdom: Historic Sales Analysis in US$ Thousand by Segment for the Period 2012-2019
    • TABLE 42: United Kingdom Cancer Gene Therapy Market Share Analysis by Segment: 2012 VS 2020 VS 2027
  • REST OF EUROPE
    • TABLE 43: Rest of Europe Cancer Gene Therapy Market Estimates and Forecasts in US$ Thousand by Segment: 2020-2027
    • TABLE 44: Cancer Gene Therapy Market in Rest of Europe in US$ Thousand by Segment: A Historic Review for the Period 2012-2019
    • TABLE 45: Rest of Europe Cancer Gene Therapy Market Share Breakdown by Segment: 2012 VS 2020 VS 2027
  • ASIA-PACIFIC
    • TABLE 46: Cancer Gene Therapy Market in Asia-Pacific by Segment: Estimates and Projections in US$ Thousand for the Period 2020-2027
    • TABLE 47: Asia-Pacific Cancer Gene Therapy Historic Market Scenario in US$ Thousand by Segment: 2012-2019
    • TABLE 48: Asia-Pacific Cancer Gene Therapy Market Share Analysis by Segment: 2012 VS 2020 VS 2027
  • REST OF WORLD
    • TABLE 49: Rest of World Cancer Gene Therapy Market Estimates and Forecasts in US$ Thousand by Segment: 2020 to 2027
    • TABLE 50: Rest of World Cancer Gene Therapy Historic Market Review by Segment in US$ Thousand: 2012-2019
    • TABLE 51: Cancer Gene Therapy Market in Rest of World: Percentage Share Breakdown of Sales by Segment for 2012, 2020, and 2027

IV. COMPETITION

  • Total Companies Profiled: 42
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.